Your browser doesn't support javascript.
loading
Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection.
Ullah, Nadeem; Hao, Ling; Wu, Yaqi; Zhang, Yandi; Lei, Qing; Banga Ndzouboukou, Jo-Lewis; Lin, Xiaosong; Fan, Xionglin.
Afiliación
  • Ullah N; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
  • Hao L; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
  • Wu Y; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
  • Zhang Y; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
  • Lei Q; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
  • Banga Ndzouboukou JL; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
  • Lin X; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
  • Fan X; Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.
J Immunol Res ; 2020: 2083793, 2020.
Article en En | MEDLINE | ID: mdl-32953889
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Adyuvantes Inmunológicos / Vacunas de Subunidad / Vacunas contra la Tuberculosis / Inmunogenicidad Vacunal / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Adyuvantes Inmunológicos / Vacunas de Subunidad / Vacunas contra la Tuberculosis / Inmunogenicidad Vacunal / Mycobacterium tuberculosis Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: China